Related Experiment Video

Updated: Aug 7, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Pathophysiology, diagnosis, and management of dyslipidemia

Gerald T Gau1, R Scott Wright

  • 1Mayo College of Medicine, USA.

Current Problems in Cardiology
|July 11, 2006
PubMed

Insights

Atherosclerosis requires managing dyslipidemia, not just revascularization, to prevent recurrence. Lipid-lowering therapies, primarily statins, are crucial for primary and secondary prevention in patients with atherosclerosis.

Area of Science:

  • Cardiovascular Medicine
  • Metabolic Disorders
  • Vascular Biology

Background:

  • Atherosclerosis is a systemic arterial disease causing stenosis and organ ischemia.
  • Revascularization treats localized symptoms but doesn't address underlying disease progression.
  • Metabolic derangements and lipoprotein abnormalities drive atherosclerosis development and recurrence.

Purpose of the Study:

  • To emphasize the critical need for treating dyslipidemia in atherosclerosis.
  • To review the role of lipid-lowering agents in managing atherosclerosis.
  • To discuss novel risk factors and patient management challenges.

Main Methods:

  • Review of current literature on atherosclerosis and dyslipidemia management.
  • Analysis of the role of lipoprotein abnormalities and lipid-lowering therapies.
  • Discussion of clinical interactions with emerging risk factors.

Main Results:

  • Percutaneous or surgical revascularization offers symptomatic relief but does not prevent disease recurrence.
  • Effective management of dyslipidemia is essential for long-term outcomes.
  • Lipid-lowering agents, predominantly statins, are key in primary and secondary prevention.

Conclusions:

  • Treating dyslipidemia is paramount in managing atherosclerosis.
  • Lipid-lowering therapies are vital for preventing atherosclerosis recurrence and progression.
  • Addressing novel risk factors and practical patient management are key for comprehensive care.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...